Roivant Sciences Ltd.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophos…
Biotechnology
GB, London [HQ]
ROIV/Financial Reporting
Income Statements
5 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue | 2.00 | 67.00 | 23.00 | 55.00 | 61.00 | |
|
EPS
|
-4.84 | 5.57 | -4.04 | -1.38 | -1.73 | |
| Diluted in mil. | -4.84 | 5.57 | -4.04 | -1.38 | -1.73 | |
|
Profit
|
1.00 | 66.00 | 21.00 | 46.00 | 48.00 | |
| Gross Margin | 73.92 | 98.33 | 91.36 | 83.78 | 78.58 | |
| Pre Tax | -807.00 | -560.00 | -898.00 | -923.00 | -1,224.00 | |
| Profit Margin | -34,732.44 | -828.77 | -3,776.20 | -1,670.85 | -1,998.75 | |
| ETR | -0.33 | -1.27 | -0.19 | -0.04 | -0.42 | |
| Net | -1,041.00 | 1,200.00 | -900.00 | -924.00 | -1,230.00 | |
| Profit Margin | -44,835.15 | 1,773.57 | -3,783.29 | -1,671.52 | -2,007.22 | |
| EBITDA | 138.00 | 83.00 | -510.00 | -1,499.00 | -1,107.00 | |
| EBITDA Margin | 5,943.46 | 123.88 | -2,145.42 | -2,712.86 | -1,807.41 | |
| Operating Income | -748.00 | -532.00 | -1,070.00 | -1,211.00 | -1,077.00 | |
| Operating Margin | -32,206.97 | -786.58 | -4,500.52 | -2,191.78 | -1,758.44 | |
| Interest Income | 5.00 | 17.00 | 1.00 | - - | 32.00 | |
| Loss | -750.00 | -600.00 | -498.00 | -1,267.00 | -1,138.00 | |
| Cost of Revenue | - - | -1.00 | -2.00 | -8.00 | -13.00 | |
|
Operating Expenses
|
-750.00 | -598.00 | -496.00 | -1,258.00 | -1,125.00 | |
| R&D | -512.00 | -263.00 | -236.00 | -483.00 | -525.00 | |
| G&A | -237.00 | -335.00 | -259.00 | -775.00 | -600.00 | |
| SG&A | -237.00 | -335.00 | -259.00 | -775.00 | -600.00 | |
| S&M | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | - - | -5.00 | -18.00 | |
| Interest Expenses | -7.00 | -7.00 | -2.00 | -7.00 | -27.00 | |
| Other Expenses | -58.00 | -28.00 | -172.00 | -288.00 | -147.00 | |
|
WA Shares Outstanding
|
215.00 | 215.00 | 222.00 | 669.00 | 712.00 | |
| Diluted | 215.00 | 215.00 | 222.00 | 669.00 | 712.00 |